109 related articles for article (PubMed ID: 15175019)
1. A theta-defensin composed exclusively of D-amino acids is active against HIV-1.
Owen SM; Rudolph D; Wang W; Cole AM; Sherman MA; Waring AJ; Lehrer RI; Lal RB
J Pept Res; 2004 Jun; 63(6):469-76. PubMed ID: 15175019
[TBL] [Abstract][Full Text] [Related]
2. RC-101, a retrocyclin-1 analogue with enhanced activity against primary HIV type 1 isolates.
Owen SM; Rudolph DL; Wang W; Cole AM; Waring AJ; Lal RB; Lehrer RI
AIDS Res Hum Retroviruses; 2004 Nov; 20(11):1157-65. PubMed ID: 15588337
[TBL] [Abstract][Full Text] [Related]
3. Retrocyclin-2: structural analysis of a potent anti-HIV theta-defensin.
Daly NL; Chen YK; Rosengren KJ; Marx UC; Phillips ML; Waring AJ; Wang W; Lehrer RI; Craik DJ
Biochemistry; 2007 Sep; 46(35):9920-8. PubMed ID: 17685559
[TBL] [Abstract][Full Text] [Related]
4. Retrocyclin, an antiretroviral theta-defensin, is a lectin.
Wang W; Cole AM; Hong T; Waring AJ; Lehrer RI
J Immunol; 2003 May; 170(9):4708-16. PubMed ID: 12707350
[TBL] [Abstract][Full Text] [Related]
5. Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry.
Yasin B; Wang W; Pang M; Cheshenko N; Hong T; Waring AJ; Herold BC; Wagar EA; Lehrer RI
J Virol; 2004 May; 78(10):5147-56. PubMed ID: 15113897
[TBL] [Abstract][Full Text] [Related]
6. The theta-defensin, retrocyclin, inhibits HIV-1 entry.
Münk C; Wei G; Yang OO; Waring AJ; Wang W; Hong T; Lehrer RI; Landau NR; Cole AM
AIDS Res Hum Retroviruses; 2003 Oct; 19(10):875-81. PubMed ID: 14585219
[TBL] [Abstract][Full Text] [Related]
7. Retrocyclin RC-101 overcomes cationic mutations on the heptad repeat 2 region of HIV-1 gp41.
Fuhrman CA; Warren AD; Waring AJ; Dutz SM; Sharma S; Lehrer RI; Cole AL; Cole AM
FEBS J; 2007 Dec; 274(24):6477-87. PubMed ID: 18028423
[TBL] [Abstract][Full Text] [Related]
8. Paradoxical effects of two theta-defensins on HIV type 1 infection.
Wang Q; Wang W; Zheng J; Tabibian S; Xie Y; Song J; Waring AJ; Chiu R; Yang OO; Chen IS; Lehrer RI; Pang S
AIDS Res Hum Retroviruses; 2007 Apr; 23(4):508-14. PubMed ID: 17506607
[TBL] [Abstract][Full Text] [Related]
9. Activity of alpha- and theta-defensins against primary isolates of HIV-1.
Wang W; Owen SM; Rudolph DL; Cole AM; Hong T; Waring AJ; Lal RB; Lehrer RI
J Immunol; 2004 Jul; 173(1):515-20. PubMed ID: 15210812
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial polypeptides are key anti-HIV-1 effector molecules of cervicovaginal host defense.
Cole AM; Cole AL
Am J Reprod Immunol; 2008 Jan; 59(1):27-34. PubMed ID: 18154593
[TBL] [Abstract][Full Text] [Related]
11. Interactions of alpha-, beta-, and theta-defensins with influenza A virus and surfactant protein D.
Doss M; White MR; Tecle T; Gantz D; Crouch EC; Jung G; Ruchala P; Waring AJ; Lehrer RI; Hartshorn KL
J Immunol; 2009 Jun; 182(12):7878-87. PubMed ID: 19494312
[TBL] [Abstract][Full Text] [Related]
12. Theta-defensins prevent HIV-1 Env-mediated fusion by binding gp41 and blocking 6-helix bundle formation.
Gallo SA; Wang W; Rawat SS; Jung G; Waring AJ; Cole AM; Lu H; Yan X; Daly NL; Craik DJ; Jiang S; Lehrer RI; Blumenthal R
J Biol Chem; 2006 Jul; 281(27):18787-92. PubMed ID: 16648135
[TBL] [Abstract][Full Text] [Related]
13. theta-Defensin pseudogenes in HIV-1-exposed, persistently seronegative female sex-workers from Thailand.
Yang C; Boone L; Nguyen TX; Rudolph D; Limpakarnjanarat K; Mastro TD; Tappero J; Cole AM; Lal RB
Infect Genet Evol; 2005 Jan; 5(1):11-5. PubMed ID: 15567134
[TBL] [Abstract][Full Text] [Related]
14. An anti-HIV microbicide engineered in commensal bacteria: secretion of HIV-1 fusion inhibitors by lactobacilli.
Pusch O; Kalyanaraman R; Tucker LD; Wells JM; Ramratnam B; Boden D
AIDS; 2006 Oct; 20(15):1917-22. PubMed ID: 16988512
[TBL] [Abstract][Full Text] [Related]
15. Antiviral activity of retrocyclin RC-101, a candidate microbicide against cell-associated HIV-1.
Gupta P; Lackman-Smith C; Snyder B; Ratner D; Rohan LC; Patton D; Ramratnam B; Cole AM
AIDS Res Hum Retroviruses; 2013 Feb; 29(2):391-6. PubMed ID: 22924614
[TBL] [Abstract][Full Text] [Related]
16. Retrocyclin: a primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1.
Cole AM; Hong T; Boo LM; Nguyen T; Zhao C; Bristol G; Zack JA; Waring AJ; Yang OO; Lehrer RI
Proc Natl Acad Sci U S A; 2002 Feb; 99(4):1813-8. PubMed ID: 11854483
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 adapts to a retrocyclin with cationic amino acid substitutions that reduce fusion efficiency of gp41.
Cole AL; Yang OO; Warren AD; Waring AJ; Lehrer RI; Cole AM
J Immunol; 2006 Jun; 176(11):6900-5. PubMed ID: 16709850
[TBL] [Abstract][Full Text] [Related]
18. Evolution of primate theta-defensins: a serpentine path to a sweet tooth.
Nguyen TX; Cole AM; Lehrer RI
Peptides; 2003 Nov; 24(11):1647-54. PubMed ID: 15019196
[TBL] [Abstract][Full Text] [Related]
19. CD4 mimetic miniproteins: potent anti-HIV compounds with promising activity as microbicides.
Van Herrewege Y; Morellato L; Descours A; Aerts L; Michiels J; Heyndrickx L; Martin L; Vanham G
J Antimicrob Chemother; 2008 Apr; 61(4):818-26. PubMed ID: 18270220
[TBL] [Abstract][Full Text] [Related]
20. Reawakening retrocyclins: ancestral human defensins active against HIV-1.
Venkataraman N; Cole AL; Ruchala P; Waring AJ; Lehrer RI; Stuchlik O; Pohl J; Cole AM
PLoS Biol; 2009 Apr; 7(4):e95. PubMed ID: 19402752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
